Impact of treatment modality on clinical outcome in metastatic colorectal cancer patients stratified by metastatic sites

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
   PubMed Web of Science ®Google Scholar
• van de Velde CJ, Boelens PG, Borras JM, et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer. 2014;50(1):1 e1–1 e34.
   Web of Science ®Google Scholar
• Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893–1907.
   PubMed Web of Science ®Google Scholar
• Eadens MJ, Grothey A. Curable metastatic colorectal cancer. Curr Oncol Rep. 2011;13(3):168–176.
   PubMed Web of Science ®Google Scholar
• Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106(7):1624–1633.
   PubMed Web of Science ®Google Scholar
• Feo L, Polcino M, Nash GM. Resection of the primary tumor in stage IV colorectal cancer: when is it necessary? Surg Clin North Am. 2017;97(3):657–669.
   PubMed Web of Science ®Google Scholar
• Damjanov N, Weiss J, Haller DG. Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. Oncologist. 2009;14(10):963–969.
   PubMed Web of Science ®Google Scholar
• Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17(12):1709–1719.
   PubMed Web of Science ®Google Scholar
• Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208–1215.
   PubMed Web of Science ®Google Scholar
• Kelly CM, Kemeny NE. Liver-directed therapy in metastatic colorectal cancer. Expert Rev Anticancer Ther. 2017;17(8):745–758.
   PubMed Web of Science ®Google Scholar
• Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver. 2013;7(1):1–6.
   PubMed Web of Science ®Google Scholar
• Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113(1):37–49.
   PubMed Web of Science ®Google Scholar
• Helou J, Thibault I, Poon I, et al. Stereotactic ablative radiation therapy for pulmonary metastases: histology, dose, and indication matter. Int J Radiat Oncol Biol Phys. 2017;98(2):419–427.
   PubMed Web of Science ®Google Scholar
• Bellier J, De Wolf J, Hebbar M, et al. Repeated resections of hepatic and pulmonary metastases from colorectal cancer provide long-term survival. World J Surg. 2018;42(4):1171–1179.
   PubMed Web of Science ®Google Scholar
• Rajakannu M, Magdeleinat P, Vibert E, et al. Is cure possible after sequential resection of hepatic and pulmonary metastases from colorectal cancer?. Clin Colorectal Cancer. 2018;17(1):41–49.
   PubMed Web of Science ®Google Scholar
• Andres A, Mentha G, Adam R, et al. Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases. Br J Surg. 2015;102(6):691–699.
   PubMed Web of Science ®Google Scholar
• Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol. 2008;26(30):4906–4911.
   PubMed Web of Science ®Google Scholar
• Shiomi K, Naito M, Sato T, et al. Effect of adjuvant chemotherapy after pulmonary metastasectomy on the prognosis of colorectal cancer. Ann Med Surg (Lond). 2017;20:19–25.
   PubMed Web of Science ®Google Scholar
• Okumura T, Boku N, Hishida T, et al. Surgical outcome and prognostic stratification for pulmonary metastasis from colorectal cancer. Ann Thorac Surg. 2017;104(3):979–987.
   PubMed Web of Science ®Google Scholar
• Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 Suppl):IV-3–18.
   Web of Science ®Google Scholar
• Qiu M, Hu J, Yang D, et al. Pattern of distant metastases in colorectal cancer: a SEER based study. Oncotarget. 2015;6(36):38658–38666.
   PubMedGoogle Scholar
• Stintzing S, Tejpar S, Gibbs P, et al. Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes. Eur J Cancer. 2017;84:69–80.
   PubMed Web of Science ®Google Scholar
• Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109(4):718–726.
   PubMed Web of Science ®Google Scholar
• Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27(22):3677–3683.
   PubMed Web of Science ®Google Scholar
• Cho JH, Kim S, Namgung M, et al. The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer. World J Surg Oncol. 2015;13:222.
   PubMed Web of Science ®Google Scholar
• Cao G, Cheng D, Ye L, et al. Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences. PLoS One. 2017;12(4):e0175284.
   PubMed Web of Science ®Google Scholar
• Tong D, Liu F, Li W, et al. The impacts of surgery of the primary cancer and radiotherapy on the survival of patients with metastatic rectal cancer. Oncotarget. 2017;8(51):89214–89227.
   PubMedGoogle Scholar
• Sabbaga J, Braghiroli MI, Hoff PM. Is surgery always necessary in rectal cancer? Oncology (Williston Park). 2014;28(7):607–611.
   PubMed Web of Science ®Google Scholar
• Van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–2545.
   PubMed Web of Science ®Google Scholar
• Dossa F, Chesney TR, Acuna SA, et al. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(7):501–513.
   PubMed Web of Science ®Google Scholar
• Cirocchi R, Trastulli S, Abraha I, et al. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev. 2012;15(8):CD008997.
   PubMed Web of Science ®Google Scholar
• Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol. 2005;12(8):637–645.
   PubMed Web of Science ®Google Scholar
• Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87(22):1686–1693.
   PubMedGoogle Scholar
• Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010;53(1):57–64.
   PubMed Web of Science ®Google Scholar
• Boisen MK, Johansen JS, Dehlendorff C, et al. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer. Ann Oncol. 2013;24(10):2554–2559.
   PubMed Web of Science ®Google Scholar
• Loupakis F, Yang D, Yau L, et al. Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst. 2015;107(3):dju427.
   PubMedGoogle Scholar